![](https://forcefieldtx.com/wp-content/uploads/2023/09/J_Tsai_0032-1300x650.jpg)
Forcefield Therapeutics appoints John Tsai MD as Chief Executive Officer
John will lead the company as CEO to explore the potential of a novel therapeutic for treatment of acute heart attacks into clinical development This novel protein technology has been shown in preclinical studies to protect heart cells and minimize the consequences of a heart attack Heart disease continues to be the number one cause…